Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
McKesson
Chinese Patent Office
McKinsey
Julphar
Mallinckrodt
Baxter
Queensland Health
Moodys

Generated: June 21, 2018

DrugPatentWatch Database Preview

SKELID Drug Profile

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Skelid, and when can generic versions of Skelid launch?

Skelid is a drug marketed by Sanofi Aventis Us and is included in one NDA.

The generic ingredient in SKELID is tiludronate disodium. There is one drug master file entry for this compound. Additional details are available on the tiludronate disodium profile page.
Drug patent expirations by year for SKELID
Synonyms for SKELID
[[(4-Chlorophenyl)thio]methylene]biphosphonic Acid Disodium Salt
149845-07-8
89987-06-4 (Parent)
AC1L1U6X
AC1NQL7O
AC1Q1UYI
AKOS015894005
AN-6422
API0004187
BH6M93CIA0
C7H8O6P2S.2Na
CAS-149845-07-8
CHEMBL1200448
Cl-TMBP
CTK8E8288
D02285
D4167
Disodium (4-chlorophenylthio)methylenediphosphonate
disodium [(4-chlorophenyl)sulfanyl-[hydroxy(oxido)phosphoryl]methyl]-hydroxy-phosphinate
disodium [(4-chlorophenyl)sulfanyl-[hydroxy(oxido)phosphoryl]methyl]-hydroxyphosphinate
Disodium [[(4-Chlorophenyl)thio]methylene]bis(hydrogenphosphonate)
Disodium dihydrogen (((p-chlorophenyl)thio)methylene)diphosphonate
Disodium Tiludronate
DisodiumTiludronate
DSSTox_CID_28547
DSSTox_GSID_48621
DSSTox_RID_82819
DTXSID1048621
FT-0675237
I04-8322
J-008635
KS-000017AP
LS-173356
NCGC00182026-01
OR223641
Phosphonic acid, (((4-chlorophenyl)thio)methylene)bis-, disodium salt
RTX-010242
SCHEMBL41053
Skelid (TN)
sr 41319b
SR 41319G
SR-41319B
TILUDRONATE DISODIUM
Tiludronate disodium (USAN)
Tiludronate disodium [USAN]
Tiludronic acid disodium salt
TILUDRONIC ACID, DISODIUM SALT
TILUDRONIC ACID,DISODIUM SALT
Tox21_112961
UNII-BH6M93CIA0

US Patents and Regulatory Information for SKELID

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sanofi Aventis Us SKELID tiludronate disodium TABLET;ORAL 020707-001 Mar 7, 1997 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

Expired US Patents for SKELID

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Sanofi Aventis Us SKELID tiludronate disodium TABLET;ORAL 020707-001 Mar 7, 1997 ➤ Sign Up ➤ Sign Up
Sanofi Aventis Us SKELID tiludronate disodium TABLET;ORAL 020707-001 Mar 7, 1997 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
Cipla
US Department of Justice
Dow
Colorcon
US Army
Fuji
McKesson
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.